↓ Skip to main content

Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?

Overview of attention for article published in Cost Effectiveness and Resource Allocation, August 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
8 Mendeley